Evidence for the Hexose Monophosphate Pathway for Glucose Metabolism in Human Pancreatic β-Cells

Nature ◽  
1960 ◽  
Vol 185 (4711) ◽  
pp. 468-469 ◽  
Author(s):  
JAMES B. FIELD ◽  
PHYLLIS JOHNSON ◽  
BETTY HERRING ◽  
ARNOLD N. WEINBERG
FEBS Letters ◽  
2009 ◽  
Vol 583 (13) ◽  
pp. 2225-2230 ◽  
Author(s):  
Masashi Yoshida ◽  
Katsuya Dezaki ◽  
Shiho Yamato ◽  
Atsushi Aoki ◽  
Hitoshi Sugawara ◽  
...  

2015 ◽  
Vol 7 (2) ◽  
pp. 171-178 ◽  
Author(s):  
Hiroki Sato ◽  
Kazuaki Nagashima ◽  
Masahito Ogura ◽  
Yuichi Sato ◽  
Yumiko Tahara ◽  
...  

2005 ◽  
Vol 289 (5) ◽  
pp. E839-E848 ◽  
Author(s):  
Leonid E. Fridlyand ◽  
Li Ma ◽  
Louis H. Philipson

Glucose metabolism stimulates insulin secretion in pancreatic β-cells. A consequence of metabolism is an increase in the ratio of ATP to ADP ([ATP]/[ADP]) that contributes to depolarization of the plasma membrane via inhibition of ATP-sensitive K+ (KATP) channels. The subsequent activation of calcium channels and increased intracellular calcium leads to insulin exocytosis. Here we evaluate new data and review the literature on nucleotide pool regulation to determine the utility and predictive value of a new mathematical model of ion and metabolic flux regulation in β-cells. The model relates glucose consumption, nucleotide pool concentration, respiration, Ca2+ flux, and KATP channel activity. The results support the hypothesis that β-cells maintain a relatively high [ATP]/[ADP] value even in low glucose and that dramatically decreased free ADP with only modestly increased ATP follows from glucose metabolism. We suggest that the mechanism in β-cells that leads to this result can simply involve keeping the total adenine nucleotide concentration unchanged during a glucose elevation if a high [ATP]/[ADP] ratio exits even at low glucose levels. Furthermore, modeling shows that independent glucose-induced oscillations of intracellular calcium can lead to slow oscillations in nucleotide concentrations, further predicting an influence of calcium flux on other metabolic oscillations. The results demonstrate the utility of comprehensive mathematical modeling in understanding the ramifications of potential defects in β-cell function in diabetes.


2003 ◽  
Vol 51 (8) ◽  
pp. 1005-1015 ◽  
Author(s):  
Seung-Hee Lee ◽  
Yu-Mi Han ◽  
Bon-Hong Min ◽  
In-Sun Park

Polyenoylphosphatidylcholine (PPC), a phosphatidylcholine-rich phospholipid extracted from soybean, has been reported to protect liver cells from alloxan-induced cytotoxicity. The present study aimed to investigate whether PPC protects pancreatic β-cells from the cytotoxic injury induced by streptozotocin, thus preserving insulin synthesis and secretion. β-Cells of the PPC-treated rats showed a significant reduction of cell death with lesser destruction of plasma membrane on streptozotocin insult. They demonstrated a rapid recovery of GLUT-2 expression, whereas almost irreversible depletion of membranebound GLUT-2 was seen in β-cells of the rats treated with only streptozotocin. A similar cytoprotective effect of PPC was also monitored in the PPC-pretreated MIN6 cells. These β-cells retained their ability to synthesize and secrete insulin and no alteration of glucose metabolism was detected. These results strongly suggest that PPC plays important roles not only in protecting β-cells against cytotoxicity but also in maintaining their insulin synthesis and secretion for normal glucose homeostasis.


1971 ◽  
Vol 49 (11) ◽  
pp. 1005-1007 ◽  
Author(s):  
R. L. Singhal ◽  
M. R. Parulekar ◽  
G. M. Ling

Three days after a single injection of streptozotocin (7.0 mg/100 g) rats showed hyperglycemia, depletion of liver glycogen, and changes in the activities of several important hepatic enzymes involved in the synthesis and utilization of glucose. The observed metabolic changes were completely reversed following administration of insulin. The insulin-induced rise in the activities of certain hepatic enzymes was inhibited by cycloheximide. The results suggest that streptozotocin can replace alloxan as a potent cytotoxic agent for pancreatic β-cells for investigating the metabolic derangement seen during diabetes.


Sign in / Sign up

Export Citation Format

Share Document